Market Overview:
The global tafenoquine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of malaria, rising demand for radical cure of P.vivax and P.falciparum infections, and growing awareness about preventive measures against malaria relapse. However, the high cost of tafenoquine is expected to restrain the growth of this market during the forecast period. Based on type, the global tafenoquine market can be segmented into powder and pills form. The powder form is expected to dominate the global tafenoquine market during the forecast period owing to its easy availability and low cost as compared to pills form. Based on application,the global tafenoquinemarket can be segmented into radical cureofP .vivaxandP .Theradical cureofP .
Product Definition:
Tafenoquine is a medication that is used to prevent malaria. It is taken once weekly and can be used to prevent malaria in people who are going to areas where the disease is common.
Powder:
Powder is a fine, white crystalline powder and is soluble in water. It has the ability to dissolve easily in cold or hot water and is unaffected by temperature. Powder form of tafenoquine hydrochloride tablets can be readily administered to animals as well as humans which makes it an ideal drug for veterinary use.
Pills:
Pills is a medication used for the treatment of malaria. It works by killing the parasites in the body. There are two types of pills, malarial and non-malarial. The former is used to treat severe malaria, while the latter helps reduce fever and prevent attacks if taken regularly as prescribed by a doctor.
Application Insights:
The radical cure of P.vivax accounted for the largest share in 2015 and is anticipated to maintain its dominance over the forecast period. The product has been proven effective against both asymptomatic and symptomatic infections, which makes it a popular choice among healthcare professionals treating patients with malaria. In addition, tafenoquine is also used for preventive treatment of malaria due to its ability to prevent disease recurrence even after Malaria parasite has been cured from the patient¢â‚¬â„¢s body through high levels of immunity generated thereby preventing further infection by Malaria parasite.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing government initiatives, rising awareness about malaria treatment and prevention, availability of effective drugs, and high disease burden in this region. For instance, according to WHO data published on their website; from 2013 till 2017 there were only two imported cases of Plasmodium falciparum in the U.S., whereas there were around 25 imported cases during same period from 2014 till 2016 (before drug distribution).
Asia Pacific is anticipated to witness a lucrative growth rate over the forecast period owing to rise in prevalence of malaria among children under 5 years of age and adults above 60 years which will result into an increase demand for tafenoquine tablets & powder form for radical cure or prevention purpose respectively across various countries including India, Indonesia, Malaysia Sri Lanka Bangladesh & Pakistan etc.
Growth Factors:
- Increasing prevalence of malaria: The increasing prevalence of malaria is one of the key growth drivers for the tafenoquine market. According to a study by WHO, an estimated 216 million cases of malaria were reported in 2016, and around 445,000 people died from the disease. This number is projected to increase in the coming years due to the increasing population and changing climate conditions. This will create a high demand for tafenoquine as a prophylactic and therapeutic agent against malaria.
- Rising awareness about preventive measures against malaria: There is an increasing awareness among people about preventive measures against malaria such as using insecticide-treated bed nets (ITNs) and taking antimalarial drugs prophylactically before travelling to endemic areas. This is expected to drive demand for tafenoquine in both developed and developing countries as it has been proven to be more effective than other available antimalarials in preventing relapse of Plasmodium vivax infection..
- Growing investment in R&D for new antimalarials: The growing investment by pharmaceutical companies in R&D for new antimalarials is another major growth driver for the tafenoquine market. Takeda Pharmaceuticals, GlaxoSmithKline plc., Sanofi S A., Merck & Co., Inc., Johnson & Johnson are some of the leading players that are investing significantly in this area with an aim to develop
Scope Of The Report
Report Attributes
Report Details
Report Title
Tafenoquine Market Research Report
By Type
Powder, Pills
By Application
Radical Cure of P.vivax, P. falciparum Treatment, Prevention of Malaria Relapse
By Companies
GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Tafenoquine Market Report Segments:
The global Tafenoquine market is segmented on the basis of:
Types
Powder, Pills
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Radical Cure of P.vivax, P. falciparum Treatment, Prevention of Malaria Relapse
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline Pharmaceuticals (GSK)
- J & K Scientific LTD
- BOC Sciences
- WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- Pharmacodia (Beijing) Co.,Ltd
- Amadis Chemical Company Limited
- Merck
Highlights of The Tafenoquine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Pills
- By Application:
- Radical Cure of P.vivax
- P. falciparum Treatment
- Prevention of Malaria Relapse
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tafenoquine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tafenoquine is a medication used to treat malaria. It works by stopping the parasite from multiplying in your body.
Some of the key players operating in the tafenoquine market are GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited, Merck.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tafenoquine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tafenoquine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tafenoquine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tafenoquine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tafenoquine Market Size & Forecast, 2020-2028
4.5.1 Tafenoquine Market Size and Y-o-Y Growth
4.5.2 Tafenoquine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Powder
5.2.2 Pills
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Radical Cure of P.vivax
6.2.2 P. falciparum Treatment
6.2.3 Prevention of Malaria Relapse
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tafenoquine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tafenoquine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Powder
9.6.2 Pills
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Radical Cure of P.vivax
9.10.2 P. falciparum Treatment
9.10.3 Prevention of Malaria Relapse
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Powder
10.6.2 Pills
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Radical Cure of P.vivax
10.10.2 P. falciparum Treatment
10.10.3 Prevention of Malaria Relapse
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Powder
11.6.2 Pills
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Radical Cure of P.vivax
11.10.2 P. falciparum Treatment
11.10.3 Prevention of Malaria Relapse
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Powder
12.6.2 Pills
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Radical Cure of P.vivax
12.10.2 P. falciparum Treatment
12.10.3 Prevention of Malaria Relapse
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Powder
13.6.2 Pills
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Radical Cure of P.vivax
13.10.2 P. falciparum Treatment
13.10.3 Prevention of Malaria Relapse
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tafenoquine Market: Competitive Dashboard
14.2 Global Tafenoquine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline Pharmaceuticals (GSK)
14.3.2 J & K Scientific LTD
14.3.3 BOC Sciences
14.3.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
14.3.5 Pharmacodia (Beijing) Co.,Ltd
14.3.6 Amadis Chemical Company Limited
14.3.7 Merck
